peepo / iStockphoto.com
Thinking about how IP can assist a company long before it has fully developed is essential, says Leda Trivinos of Flagship Pioneering in an interview with LSIPR.
“This job is a blessing,” says Leda Trivinos, adding that “working on the cutting edge of science with incredibly talented, intelligent and out-of-the-box thinkers is exciting and rewarding.”
Trivinos joined US-based Flagship Pioneering, a business that creates and manages life sciences ventures, as an IP partner in 2015.
At Flagship, she works with a team of “entrepreneurial scientists”—Flagship’s partners, principals and associates—to develop IP strategy and build strong patent portfolios for inventions that are ultimately used by its life sciences ventures.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
LSIPR 2017, Leda Trivinos, life sciences, ventures, patent portfolios, Flagship Pioneering,
